Global Way: How far will the momentum go?! Ren Science consecutive S-high‼️

Lena Science Trading is halted at the limit-up level of 498 yen, with a price gap up. After the close on the 17th, they announced that they had entered into a collaborative research agreement with Tokyo Medical and Dental University Hospital, and this is being viewed as positive material. From the collaboration with Northwestern University in the United States, there are indications (non-clinical studies) that the PA-1 inhibitor RS5614 developed by the company may be effective as a treatment for FG F23-related hypophosphatemic rickets. The company states that under this collaborative research agreement it will conduct a clinical study with Tokyo Medical and Dental University Hospital to explore the efficacy and safety of RS5614 in patients with FG F23-related hypophosphatemic rickets. It also notes that there is no forecast revision for the year ending March 2022 as a result of this matter.